The independent source for health policy research, polling, and news.
Showing 41 - 60 of 117
The technology has generated notices with errors, sent Medicaid paperwork to the wrong addresses, and been frozen for hours at a time, according to state audits, court documents, and interviews. While it can take months to fix problems, America’s poorest residents pay the price.
Clinicians working for Ascension hospitals in multiple states described harrowing lapses, including delayed or lost lab results, medication errors, and an absence of routine safety checks to prevent potentially fatal mistakes.
A new analysis shows that students graduating from U.S. medical schools were less likely to apply this year for residency positions in states with abortion bans and other significant abortion restrictions.
Republicans are learning the admonition “be careful what you wish for,” as conservative judges cause them political problems over abortion in a crucial election year.
As money flows to abortion rights initiatives in states, some donors focus on where anger over the "Dobbs" ruling could propel voter turnout and spur Democratic victories up and down the ballot, including in key Senate races and the White House.
The expansion of Catholic hospitals nationwide leaves patients at the mercy of the church’s religious directives, which are often at odds with accepted medical standards.
The bottleneck caused by states’ reevaluation of Medicaid enrollees has swept up low-income families that rely on other safety-net services.
Anti-abortion groups have lost seven consecutive elections on state ballot measures about abortion. They say they’re unfazed and plan to keep focusing on lawmakers and courts to notch wins.
The state canceled Beverly Likens’ coverage — days before surgery — without considering other ways she qualified for Medicaid, which experts say violated federal regulations.
Convenient as it may be, beware of getting your blood drawn at a hospital. The cost could be much higher than at an independent lab, and your insurance might not cover it all.
A KFF survey of employer health benefits shows that 28% of large U.S. companies have limited or no access to abortion under company health insurance.
The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?
The Centers for Medicare & Medicaid Services backed off from a plan that could have curtailed access to a type of reconstructive surgery known as DIEP flap. Breast cancer patient advocates are relieved.
Mandy Cohen, the new director of the Centers for Disease Control and Prevention, earned praise for her leadership and communication as the face of North Carolina’s response to covid-19. People in the state’s most vulnerable communities tell a more complicated story.
Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.
The federal government’s arcane process for medical coding is influencing which reconstructive surgery options are available, creating anxiety for breast cancer patients.
Family planning clinics are getting caught between state abortion bans and a federal requirement to refer patients for abortion care on request.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF